Clinical Trials Browser

Central Nervous System Diseases × tipifarnib × Clear all

NCT00050986 2020-09-22

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Phase 1/2 Completed

55 enrolled 6 charts

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma